Skip to main content
    B

    Becton Dickinson and Company (BDX)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NYSE

    $215.44
    -1.03 (-0.48%)

    Market Cap: $58.96B

    Last updated: Nov 17, 2026 at 4:24 PM ET

    Becton Dickinson and Company (BDX) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Becton Dickinson and Company (BDX) has a market cap of $58.96B and an enterprise value of $75.06B. Its share count is down 4.97% from a year earlier. Its return on invested capital of 4.99% compares with a 10.24% median across 11 similar companies.

    Total Valuation

    Enterprise value is 27.30% above the market cap, as debt exceeds cash.

    Market Cap$58.96B
    Enterprise Value$75.06B
    Latest price (Nov 17, 2026)$215.44

    Key Dates

    The next earnings report is expected on Feb 8, 2027, covering the quarter ending Dec 31, 2026. The next ex-dividend date is Dec 10, 2026.

    Next Earnings DateFeb 8, 2027 (expected)
    Last Earnings DateNov 5, 2026
    Next Ex-Dividend DateDec 10, 2026
    Next Payment DateDec 31, 2026
    Fiscal Year EndSeptember

    Share Statistics

    The share count fell 1.14% in the quarter ended Jun 30, 2026 and shrank 2.92% a year over 2 years.

    Shares Outstanding272.39M
    Shares Change (YoY)-4.97%
    Shares Change (QoQ)-1.14%
    Share Count Growth (2Y CAGR)-2.92%

    Valuation Ratios

    Sales and book value multiples are 2.6x and 2.4x. Its year-end P/E ranged from 14.0x to 23.4x from 2016 to 2025.

    P/E Ratio16.3x
    Forward P/E16.0x
    P/S Ratio2.6x
    Forward P/S3.0x
    P/B Ratio2.4x
    P/FCF Ratio18.3x
    P/OCF Ratio14.9x
    PEG Ratio2.5

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 15.5x EBITDA and 23.3x free cash flow.

    EV / Earnings79.8x
    EV / Sales3.3x
    EV / EBITDA15.5x
    EV / EBIT31.8x
    EV / FCF23.3x

    Price Statistics

    The stock is up 44.65% over 52 weeks and trades 12.04% above its 50-day average.

    Beta (1Y)0.26
    52-Week Change+44.65%
    1-Month Change+12.95%
    3-Month Change+15.51%
    6-Month Change+48.48%
    5-Year Change-17.41%
    10-Year Change+17.85%
    Total Return (1Y)+47.32%
    Total Return (3Y CAGR)+7.48%
    Total Return (5Y CAGR)+4.14%
    Return vs SPY (1Y)+33.63%
    Max Drawdown (1Y)-23.53%
    Max Drawdown (3Y)-33.39%
    Sharpe Ratio (1Y)1.43
    Correlation with SPY (1Y)0.14
    50-Day Average$192.29
    200-Day Average$168.00
    52-Week Range$139.29 to $220.36
    RSI (14 Days)69.8
    Average Volume (20 Days)2.03M

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 0.87x current liabilities, and total debt is 0.69x shareholder equity.

    Current Ratio0.87x
    Quick Ratio0.51x
    Debt / Equity0.69x
    Debt / EBITDA3.49x
    Debt / FCF5.25x
    Interest Coverage4.00x

    Returns and Efficiency

    Return on invested capital is 4.99% over the last 12 months, against a 5-year average of 4.72%.

    Return on Equity (ROE)3.85%
    Return on Assets (ROA)1.85%
    Return on Invested Capital (ROIC)4.99%
    Return on Capital Employed (ROCE)5.71%
    ROE (5Y Average)6.96%
    ROA (5Y Average)3.21%
    ROIC (5Y Average)4.72%
    Asset Turnover0.42x
    Inventory Turnover3.58x
    Receivables Turnover9.81x
    Cash Conversion Cycle-45 days

    Taxes

    Income tax took 12.73% of pretax income over the last 12 months.

    Income Tax (TTM)$228.00M
    Effective Tax Rate12.73%

    Scores

    BDX has an Altman Z-Score of 2.39, in the grey zone from 1.81 to 2.99, and a Piotroski F-Score of 7 of 9, in the average band of 3 to 7.

    Altman Z-Score2.39
    Altman Z ZoneGrey
    Piotroski F-Score7 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $22.41B over the last 12 months is up 13.14% from the 12 months before.

    Revenue$22.41B
    Revenue Growth (YoY)+13.14%
    Gross Profit$10.47B
    Operating Income$2.31B
    Pretax Income$1.79B
    Net Income$941.00M
    EBITDA$4.81B
    EBIT$2.36B
    Reported EPS (TTM)$13.19

    Trailing 12 months through Jun 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 48.14% of the $50.73B in total assets.

    Cash and Equivalents$708.00M
    Total Debt$16.81B
    Net Debt$16.10B
    Net Debt Per Share$59.11
    Working Capital-$1.26B
    Shareholder Equity$24.42B
    Book Value Per Share$89.64
    Tangible Book Value-$3.89B
    Total Assets$50.73B
    Total Liabilities$26.31B

    Balance sheet as of Jun 30, 2026.

    Full balance sheet

    Cash Flow

    After $753.00M of capital spending, operating cash flow left $3.20B of free cash flow.

    Operating Cash Flow$3.96B
    Capital Expenditures$753.00M
    Free Cash Flow$3.20B
    FCF Per Share$11.76
    Depreciation and Amortization$2.45B
    Dividends Paid$1.17B

    Trailing 12 months through Jun 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 10.31%, against a 5-year average of 11.69%.

    Gross Margin46.73%
    Operating Margin10.31%
    Pretax Margin7.99%
    Net Margin4.20%
    EBITDA Margin21.46%
    EBIT Margin10.52%
    FCF Margin14.29%
    Gross Margin (5Y Average)44.58%
    Operating Margin (5Y Average)11.69%
    Net Margin (5Y Average)8.83%

    Growth

    Revenue grew 4.99% a year over 3 years, and EPS 2.58% a year.

    Revenue Growth (3Y CAGR)+4.99%
    Revenue Growth (5Y CAGR)+6.32%
    EPS Growth (3Y CAGR)+2.58%
    EPS Growth (5Y CAGR)+0.18%
    FCF Growth (3Y CAGR)+21.25%
    FCF Growth (5Y CAGR)+4.25%
    Operating Income Growth (3Y CAGR)+4.16%
    Book Value Per Share Growth (2Y CAGR)+0.17%

    Revenue and profit by year

    Dividends and Yields

    BDX pays out 27.37% of earnings as dividends.

    Dividend Per Share (Annual)$4.20
    Dividend Yield1.95%
    Payment ScheduleQuarterly
    Dividend Growth (3Y CAGR)+5.81%
    Dividend Growth (5Y CAGR)+5.44%
    Payout Ratio27.37%
    FCF Payout Ratio36.59%
    Earnings Yield6.13%
    FCF Yield5.46%
    Buyback Yield4.26%
    Shareholder Yield6.26%

    Full dividend history

    Peer Position

    Against 12 similar companies, BDX has the 9th highest P/E and the 9th highest P/S.

    P/E Ratio16.3x vs 20.7x median
    P/S Ratio2.6x vs 3.4x median
    ROIC4.99% vs 10.24% median
    Revenue Growth (Trailing 4 Quarters, YoY)+13.14% vs +9.05% median
    Dividend Yield1.95% vs 0.00% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put EPS growth at 3.85% a year over the next 2 fiscal years.

    EPS Growth Forecast (2Y CAGR)+3.85%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About BDX

    What is BDX's market cap?

    Becton Dickinson and Company has a market cap of $58.96B. Its enterprise value, which adds debt and subtracts cash, is $75.06B.

    What is BDX's P/E ratio?

    Becton Dickinson and Company has a trailing P/E ratio of 16.3x and a forward P/E of 16.0x.

    How many shares of BDX are outstanding?

    Becton Dickinson and Company has 272.39M shares outstanding. The count is down 4.97% from a year earlier.

    Does BDX pay a dividend?

    Yes. Becton Dickinson and Company pays $4.20 a share a year, a dividend yield of 1.95%.

    How much debt does BDX have?

    Becton Dickinson and Company has $16.81B of total debt and $708.00M of cash and equivalents, a net debt position of $16.10B.